Whole-Brain T1 Mapping in Multiple Sclerosis: Global Changes of Normal-appearing Gray and White MatterHugo Vrenken, Petra J. W. Pouwels, Jeroen J.G. Geurts et al.|Radiology|2006Cited by 206
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosisDaniel R. Altmann, D. H. Miller, Bas Jasperse et al.|Neurology|2008Cited by 100
Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI dataJaume Sastre‐Garriga, Alan J. Thompson, Gordon Ingle et al.|Neurology|2005Cited by 68
Motor evoked potential: A reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRINynke F. Kalkers, Cornelis J. Stam, R.L.M. Strijers et al.|Clinical Neurophysiology|2007Cited by 40
Determinants of Cerebral Atrophy Rate at the Time of Diagnosis of Multiple SclerosisBas Jasperse, Chris H. Polman, A. Minneboo et al.|Archives of Neurology|2007Cited by 32